Scientific publications

Cyclosporin A in the treatment of Eaton-Lambert myasthenic syndrome

Yuste Ara JR [SP], Beloqui Ruiz O, Artieda Gonzalez-Granda J [SP], Herrero Santos JI, De la Peña Fernandez A, Prieto Valtueña J.
Departamento de Medicina Interna, Universidad de Navarra, Pamplona.

Magazine: Anales de Medicina Interna

Date: Jan 1, 1996

Neurophysiology [SP] Internal Medicine [SP]

The Lambert-Eaton myasthenic syndrome (LEMS) is a disorder of he cholinergic neurotransmition at the presinaptic terminal of the neuromuscular junction.

Clinically it is characterized by muscular weakness, hyporeflexia and autonomic dysfunction. In this entity thet presence of antibodies against calcium channels impair acetylcholine release.

Whe used cyclosporin-A in a patient with LEMS and this resulted in a complete clinical and neurophysiological recovery after four months of therapy.

CITATION  An Med Interna. 1996 Jan;13(1):25-6

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra